Drug Side Effects
Search
OVARIAN ENDOMETRIOID CARCINOMA
OVARIAN ENDOMETRIOID CARCINOMA
was reported 42 times
OVARIAN ENDOMETRIOID CARCINOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Androgen [EPC]
10
0.0004
1
Aromatase Inhibitor [EPC]
6
0.0001
2
Microtubule Inhibitor [EPC]
6
0.0000
3
Estrogen Receptor Antagonist [EPC]
1
0.0000
4
Integrin Receptor Antagonist [EPC]
2
0.0000
5
gamma-Aminobutyric Acid-ergic Agonist [EPC]
2
0.0000
6
Serotonin Reuptake Inhibitor [EPC]
2
0.0000
7
Platinum-based Drug [EPC]
6
0.0000
8
Vascular Endothelial Growth Factor Inhibitor [EPC]
3
0.0000
9
Dietary Cholesterol Absorption Inhibitor [EPC]
1
0.0000
10
Kinase Inhibitor [EPC]
6
0.0000
11
Purine Antimetabolite [EPC]
1
0.0000
12
Interleukin-12 Antagonist [EPC]
1
0.0000
13
Interleukin-23 Antagonist [EPC]
1
0.0000
14
Thiazide Diuretic [EPC]
1
0.0000
15
Vitamin C [EPC]
2
0.0000
16
Alkylating Drug [EPC]
1
0.0000
17
Tumor Necrosis Factor Blocker [EPC]
4
0.0000
18
Factor Xa Inhibitor [EPC]
1
0.0000
19
beta-Adrenergic Blocker [EPC]
1
0.0000
20
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
21
Insulin Analog [EPC]
1
0.0000
22
Platelet Aggregation Inhibitor [EPC]
1
0.0000
23
Proton Pump Inhibitor [EPC]
1
0.0000
24
Corticosteroid [EPC]
2
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000